Background/Aim: There are few reports that verify the relationship between the therapeutic
effects of flutamide and novel androgen receptor-targeted agents. We aimed to evaluate the …

Abstract Objective In Japan, flutamide had been commonly used as second-line alternative
antiandrogen hormonal therapy for metastatic castration-resistant prostate cancer that …

Objectives: To analyze the clinical effects of flutamide as a second‐line anti‐androgen for
combined androgen blockade in patients with castration‐resistant prostate cancer (CRPC) …

OBJECTIVE To investigate the efficacy of low‐dose flutamide (125 mg twice daily) in the
treatment of prostate‐specific antigen (PSA) recurrence after definitive treatment with radical …

Background: Some authors have recently reported that maximum androgen block (MAB), in
which the nonsteroidal anti–androgen, flutamide, is used together with conventional …

Alternative Antiandrogen Therapy with Flutamide in Patients with Castration-Resistant
Prostate Cancer: A Single Center Experience We analyzed the clinical effects of flutamide …

Background: In a recent study by the Casodex Combination Study Group, USA, patients in a
flutamide (750mg/day) plus LH‐RH agonist group showed a high treatment failure rate …

The efficacy of combined androgen blockade therapy consisting of flutamide, a nonsteroidal
antiandrogen, plus an LH-RH agonist (F-CAB) was investigated in Japanese patients with …

OBJECTIVES To investigate the efficacy of maximum androgen blockade (MAB) using
flutamide as second‐line hormonal therapy for advanced hormone‐refractory prostate …

Among all hormone-sensitive cancers, prostate cancer is recognised as being the most
sensitive. In fact, the best known characteristic of prostate cancer is its marked sensitivity to …